Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
100%
Pharmacovigilance
47%
Disproportionality Analysis
36%
Mouse
34%
Retrospective Study
32%
Cisplatin
31%
Immune Checkpoint Inhibitor
31%
Nephrotoxicity
30%
Vancomycin
30%
Adverse Drug Reaction
27%
Acute Kidney Failure
26%
Interstitial Lung Disease
24%
Proton Pump Inhibitor
24%
Kidney Injury
22%
Myocarditis
19%
Hepcidin
15%
Cardiovascular Toxicity
15%
Irinotecan
15%
Malignant Neoplasm
14%
Drug Repositioning
13%
Statin (Protein)
13%
Rhabdomyolysis
10%
Chronic Kidney Failure
10%
Cardiotoxicity
9%
Vasculotropin
9%
Chemotherapy
9%
Aromatic Hydrocarbon Receptor
9%
Therapeutic Effect
9%
Neutropenia
9%
Prevalence
8%
Thiazide Diuretic Agent
8%
Pembrolizumab
8%
Ipilimumab
8%
Nivolumab
8%
Clinical Study
8%
Piperacillin Plus Tazobactam
8%
Lung Cancer
8%
Concomitant Drug
8%
Epidermal Growth Factor Receptor
8%
Congestive Heart Failure
8%
Nausea and Vomiting
8%
Palonosetron
8%
Clinical Trial
8%
Serotonin 3 Antagonist
8%
Indican
7%
Bovine Serum Albumin
7%
Gamma Interferon
7%
Delirium
7%
Anaplastic Lymphoma Kinase Inhibitor
7%
Ferroptosis
7%
Keyphrases
Concomitant Use
16%
Real-time Database
15%
Immune Checkpoint Inhibitors
15%
Japan
15%
VigiBase
8%
Pharmacovigilance Database
8%
University Hospital
8%
Thiazide Diuretics
7%
Cisplatin-induced Kidney Injury
7%
Nephrotoxin
7%
Vancomycin
7%
Life-science Databases
7%
Big Data Analysis
7%
Interstitial Lung Disease
7%
Medical Sciences
7%
Synthase-dependent Pathway
7%
Patient Analysis
7%
Retrospective Analysis
7%
Pretreatment Effect
7%
Lung Cancer Patients
7%
Ferroptosis
7%
Factor Xa Inhibitors
7%
Spontaneous Reporting Database
7%
Renoprotective Effect
7%
Rash
7%
Pemetrexed
7%
Japanese Claims Database
7%
Database Analysis
7%
Nicardipine Hydrochloride
7%
Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor (EGFR-TKI)
7%
Real-world Pharmacovigilance
7%
Myocarditis
7%
Low-dose Corticosteroids
7%
Kidney Toxicity
7%
Triple Whammy
7%
Iron Restriction
7%
Pre-exposure Prophylaxis (PrEP)
7%
Protein Overload
7%
Dietary Iron
7%
Drug Repositioning
7%
Arterial Thrombus
7%
Vancomycin-induced Nephrotoxicity
7%
Safety Database
7%
Phase II Study
7%
Investigator-initiated
7%
Unilateral Ureteral Obstruction
7%
Nephrotoxicity
7%
Clinical Trials Act
7%
Musculoskeletal Adverse Event
7%
Renal Hypoperfusion
7%
Medicine and Dentistry
Adverse Event
15%
Mortality Rate
11%
Oxidative Stress
9%
Macrophage
9%
Clinical Trial
8%
Pharmacovigilance
7%
Nephrotoxicity
7%
Drug Therapy
7%
Interstitial Lung Disease
7%
Cancer Cell
7%
Immune Checkpoint Inhibitor
7%
Lung Cancer
7%
Clinical Study
7%
Ferritin
7%
Epidermal Growth Factor Receptor
7%
Vancomycin
7%
Blood Clotting Factor 10a Inhibitor
7%
Erythropoietin
7%
Head and Neck Cancer
7%
Cancer Mortality
7%
Diabetes
7%
Prothrombin
7%
Cabozantinib
7%
Vonoprazan
7%
Vasopressin Receptor Antagonist
7%
Hypoxia Inducible Factor
7%
Lipid Diet
7%
Nivolumab
7%
Ipilimumab
7%
Proton-Pump Inhibitor
7%
Vasculotropin
7%
Ureter Obstruction
7%
Cost-Effectiveness Analysis
7%
Biosimilar
7%
Trastuzumab
7%
Observational Study
7%
Biliary Tract Cancer
7%
Odds Ratio
6%
Diet Restriction
5%
Cholangiocarcinoma
5%